Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya

Bibliographic Details
Main Authors:	G.C. Coles, Y.S. Liang, M.J. Doenhoff
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2001-12-01
Series:	Emerging Infectious Diseases
Subjects:	Schistosoma haematobium praziquantel resistance helminths Kenya
Online Access:	https://wwwnc.cdc.gov/eid/article/7/6/01-0633_article

Similar Items

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya--Reply to Drs. Coles, Liang, and Doenhoff
by: C. H. King, et al.
Published: (2001-12-01)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
by: Jana Kovač, et al.
Published: (2017-08-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
by: Calvin Bisong Ebai, et al.
Published: (2017-12-01)

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01)

Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa
by: Muhubiri Kabuyaya, et al.
Published: (2017-04-01)

Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial
by: Jean T. Coulibaly, et al.
Published: (2018-06-01)

Prevalence and factors associated with ongoing transmission of Schistosoma haematobium after 12 rounds of Praziquantel Mass Drug Administration among school age children in Southern Tanzania
by: Ditrick Malibiche, et al.
Published: (2023-11-01)

Haematological and Biochemical Morbidity of Schistosoma Haematobium in School Children in Sudan
by: Elagba HA Mohammed, et al.
Published: (2006-12-01)

Spatial distribution and ecology of soil parasites and Schistosoma haematobium infection in Eggua, Nigeria
by: Taiwo A Adekeye, et al.
Published: (2021-10-01)

Transmission sites for Schistosoma haematobium and Schistosoma bovis identified in localities within the Athi River basin of Kenya using a PCR-RFLP assay
by: Eric L. Agola, et al.
Published: (2021-02-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Persistent Urogenital Schistosomiasis and Its Associated Morbidity in Endemic Communities within Southern Ghana: Suspected Praziquantel<i> </i>Resistance or Reinfection?
by: Patience B. Tetteh-Quarcoo, et al.
Published: (2020-02-01)

Age-targeted chemotherapy for control of urinary schistosomiais in endemic populations
by: Charles H. King, et al.
Published: (1992-01-01)

Dynamics of <it>Schistosoma haematobium </it>egg output and associated infection parameters following treatment with praziquantel in school-aged children
by: Stete Katarina, et al.
Published: (2012-12-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
by: Eglal I. Amer, et al.
Published: (2022-03-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
by: Jean T. Coulibaly, et al.
Published: (2018-06-01)

Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
by: Muhubiri Kabuyaya, et al.
Published: (2018-07-01)

In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
by: Xiaoli Wang, et al.
Published: (2019-05-01)

Schistosoma haematobium–Schistosoma mansoni Hybrid Parasite in Migrant Boy, France, 2017
by: Yohann Le Govic, et al.
Published: (2019-02-01)

The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
by: Mutapi Francisca, et al.
Published: (2002-01-01)

Cercarial emergence pattern of Schistosoma haematobium from Libreville, Gabon
by: Mintsa-Nguéma Rodrigue, et al.
Published: (2014-01-01)

A new rapid diagnostic test for detection of anti-<it>Schistosoma mansoni</it> and anti-<it>Schistosoma haematobium</it> antibodies
by: Coulibaly Jean T, et al.
Published: (2013-01-01)

Case series of adenocarcinoma of the prostate associated with Schistosoma haematobium infection in Tanzania
by: Humphrey D Mazigo, et al.
Published: (2010-01-01)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2019-12-01)

Genetic profiles of Schistosoma haematobium parasites from Malian transmission hotspot areas
by: Privat Agniwo, et al.
Published: (2023-08-01)

Hybridization increases genetic diversity in Schistosoma haematobium populations infecting humans in Cameroon
by: Félicité Flore Djuikwo Teukeng, et al.
Published: (2022-03-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

HESTOPATHOGLOGICAL STUDIES ON MIGRATION OF SCHISTOSOMA HAEMATOBIUM AND SCHISTOSOMA MANSONI LARVAE IN LABORATORY ANIMALS
by: M.R.Nazari, et al.
Published: (1985-06-01)

Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
by: Nada Abdel Aziz, et al.
Published: (2019-12-01)

Prevalence of <i>Schistosoma haematobium</i> and Intestinal Helminth Infections among Nigerian School Children
by: Tolulope Alade, et al.
Published: (2023-02-01)

Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel
by: Patrícia Ivana Pires Bonesso-Sabadini, et al.
Published: (2002-04-01)

Polyparasitism with Schistosoma haematobium, Plasmodium and soil-transmitted helminths in school-aged children in Muyuka–Cameroon following implementation of control measures: a cross sectional study
by: Irene Ule Ngole Sumbele, et al.
Published: (2021-02-01)

Effect of pre-existing Schistosoma haematobium infection on Plasmodium berghei multiplications in imprinting control region mice
by: Benjamin Amoani, et al.
Published: (2015-06-01)

Urinary schistosomiasis in Nigeria: a 50 year review of prevalence, distribution and disease burden
by: Ezeh Charles Ogbonna, et al.
Published: (2019-01-01)

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries
by: Ye Shen, et al.
Published: (2017-09-01)

Schistosoma haematobium infection in a returning Chinese worker
by: Neng Wang, et al.
Published: (2023-05-01)